Article info
PDFResponse
Expanding insurance coverage for in vitro fertilisation with preimplantation genetic testing: putting the cart before the horse
Citation
Expanding insurance coverage for in vitro fertilisation with preimplantation genetic testing: putting the cart before the horse
Publication history
- Received September 23, 2020
- Revised January 16, 2021
- Accepted January 21, 2021
- First published February 19, 2021.
Online issue publication
March 01, 2022
Article Versions
- Previous version (1 March 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Preimplantation genetic testing
- In vitro fertilisation with preimplantation genetic testing: the need for expanded insurance coverage
- Clinical applications of preimplantation genetic testing
- Genetic testing and reproductive choice in neurological disorders
- Exceptional know how? Possible pitfalls of routinising genetic services
- Making the ‘genetic counsellor’ in the UK, 1980–1995
- Would you terminate a pregnancy affected by sickle cell disease? Analysis of views of patients in Cameroon
- Co-design of patient information leaflets for germline predisposition to cancer: recommendations for clinical practice from the UK Cancer Genetics Group (UKCGG), Cancer Research UK (CRUK) funded CanGene-CanVar Programme and the Association of Genetic Nurse Counsellors (AGNC)
- A model for the return and referral of all clinically significant secondary findings of genomic sequencing
- The challenge of integrating genetic medicine into primary care